COUNTERPOINT: Should Triple Inhaled Therapy Be Considered in All Patients With Group E COPD? No

Chest. 2024 Jul;166(1):17-20. doi: 10.1016/j.chest.2024.03.031.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Administration, Inhalation
  • Bronchodilator Agents* / administration & dosage
  • Bronchodilator Agents* / therapeutic use
  • Drug Therapy, Combination
  • Humans
  • Pulmonary Disease, Chronic Obstructive* / drug therapy

Substances

  • Bronchodilator Agents